|
Jun 21
|
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
|
|
Jun 21
|
Jazz Pharmaceuticals’ essential tremor drug falls flat in Phase IIb trial
|
|
Jun 20
|
Jazz Dives — But Key Rival Praxis Surges — On Essential Tremor Drug Failure
|
|
Jun 20
|
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
|
|
Jun 11
|
‘Load Up,’ Says Goldman Sachs About These 2 Strong Buy Stocks
|
|
May 22
|
Jazz Pharmaceuticals Announces Collaboration With Life Science Cares To Improve the Wellbeing of Under Resourced Communities Through Employee Volunteerism
|
|
May 9
|
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
|
|
May 8
|
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
|
|
May 7
|
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript
|
|
May 6
|
Jazz (JAZZ) International Revenue Performance Explored
|
|
May 3
|
Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
|
|
May 1
|
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 1
|
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
|
|
May 1
|
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
|
|
Apr 25
|
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 24
|
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
|
|
Apr 24
|
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Apr 24
|
3 No-Brainer Stocks to Buy With $300 Right Now
|
|
Apr 22
|
A Closer Look At Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Uninspiring ROE
|
|
Apr 17
|
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
|